These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9004094)

  • 1. Recent data on hypertension and progressive renal disease.
    Zucchelli P; Zuccalà A
    J Hum Hypertens; 1996 Oct; 10(10):679-82. PubMed ID: 9004094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Locatelli F; Carbarns IR; Maschio G; Mann JF; Ponticelli C; Ritz E; Alberti D; Motolese M; Janin G; Zucchelli P
    Kidney Int Suppl; 1997 Dec; 63():S63-6. PubMed ID: 9407424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benazepril and the kidney: new indication. No better than the other ACE inhibitors.
    Prescrire Int; 1998 Dec; 7(38):174-6. PubMed ID: 10848048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertensive renal vascular disease and cardiovascular endpoints.
    Matavelli LC; Zhou X; Frohlich ED
    Curr Opin Cardiol; 2006 Jul; 21(4):305-9. PubMed ID: 16755198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of acute functional injury following percutaneous renal artery intervention.
    Davies MG; Saad WE; Peden EK; Mohiuddin IT; Naoum JJ; Lumsden AB
    Ann Vasc Surg; 2008 Nov; 22(6):783-9. PubMed ID: 18692990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Better understanding of atheromatous ischemic renal vascular disease].
    Mounier-Vehier C; Jaboureck O; Willoteaux S; Gautier C; Dequiedt P; Carré A
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1449-58. PubMed ID: 11190295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression of renal insufficiency and platelet activating factor (PAF)].
    Camici M
    Minerva Med; 1996 Jun; 87(6):289-98. PubMed ID: 8700358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive renal failure. Why blood pressure must now be monitored].
    Tepel M; van der Giet M; Zidek W
    MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reno-ureteral diseases inducing hypertension in children.
    Burnei G; Burnei A; Hodorogea D; Gavriliu S; Georgescu I; Vlad C; Hurmuz L; Dan D
    Rom J Intern Med; 2008; 46(4):367-74. PubMed ID: 19480305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and progression of renal disease.
    Maschio G; Oldrizzi L; Marcantoni C; Rugiu C
    J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current thoughts on the management of renovascular disease.
    Hines GL
    Heart Dis; 2000; 2(2):118-23. PubMed ID: 11728249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does essential hypertension cause progressive renal disease?
    Fliser D; Ritz E
    J Hypertens Suppl; 1998 Sep; 16(4):S13-5. PubMed ID: 9817187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists and renal protection: emerging perspectives.
    Epstein M
    J Hypertens Suppl; 1998 Sep; 16(4):S17-25. PubMed ID: 9817188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The kidneys and hypertension].
    Hausberg M; Mann J; Kühn K
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1853-6. PubMed ID: 18770487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?
    Johnson RJ; Segal MS; Srinivas T; Ejaz A; Mu W; Roncal C; Sánchez-Lozada LG; Gersch M; Rodriguez-Iturbe B; Kang DH; Acosta JH
    J Am Soc Nephrol; 2005 Jul; 16(7):1909-19. PubMed ID: 15843466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of renal failure in hypertension. The role of genetic factors, low weight at birth and endothelial dysfunction].
    Caridi G; Zoccali C
    Recenti Prog Med; 2005 Apr; 96(4):205-10. PubMed ID: 15932040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.